Aktiesnakken — Februar 2010
-
-
morgen pliiing
-
hvad er et for en aftale genmab har brudt, og hvorfor?
-
what?
-
2 sek
-
-
07:18
Biotekselskabet Genmab har afbrudt en aftale med Facet Biotech per 5. november og skal derfor tilbagebetale 4,88 mio. dollar til se -
til selskabet
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind